Tag: WHO Guidelines

Impact of Equipment Qualification Failures on Ongoing Stability Studies

In the highly regulated pharmaceutical environment, equipment qualification is a cornerstone of ensuring data integrity and product stability. When equipment such as stability chambers, temperature loggers, or photostability enclosures fail to meet qualification requirements, it poses a significant risk to ongoing stability studies. These failures may result in invalidated data, batch rejection, and even regulatory…

Equipment and Calibration, Impact of Equipment Deviations on Stability Data

Integrating Qualification Protocols with Stability Study Start: GMP-Compliant Approach

🌍 Why Equipment Qualification Must Align with Stability Study Start In pharmaceutical and clinical settings, the start of a stability study is a critical milestone—especially when linked to product shelf-life decisions and regulatory submissions. However, initiating a study without ensuring that all associated equipment (e.g., stability chambers, temperature/humidity monitors) is fully qualified can lead to…

Equipment and Calibration

Align Stability Study Designs with Climatic Zone Requirements

Understanding the Tip: Why climatic zones influence stability study design: Pharmaceutical products are distributed globally, and their stability must be assured under varying environmental conditions. Regulatory bodies group the world into climatic zones (I–IV) based on temperature and humidity patterns. Each zone has specific requirements for long-term, intermediate, and accelerated stability studies. Designing a one-size-fits-all…

Stability Study Tips

Plan Comparative Stability Studies for Biosimilars vs. Reference Product

Understanding the Tip: Why comparative stability is crucial in biosimilar development: Unlike generics, biosimilars must demonstrate similarity to a reference biologic across quality, safety, and efficacy attributes—including degradation behavior. Comparative stability studies provide critical evidence that the biosimilar maintains quality over time in a manner equivalent to the reference. These studies help confirm that the…

Stability Study Tips

Plan Comparative Stability Studies for Biosimilars vs. Reference Product

Understanding the Tip: Why comparative stability matters for biosimilars: Biosimilars must establish similarity not only in terms of structure, function, and clinical performance but also in stability behavior. Comparative stability studies help demonstrate that the biosimilar and its reference product degrade in a similar manner under identical conditions. This supports the claim of “no clinically…

Stability Study Tips

Checklist for GMP Compliance in Stability Chambers

Stability chambers are critical assets in any pharmaceutical quality system. These controlled environments support the long-term and accelerated stability studies required by global regulatory bodies. To maintain data integrity and meet GMP expectations, stability chambers must comply with stringent validation, maintenance, and monitoring protocols. This checklist ensures your chambers are always audit-ready and functionally reliable….

Good Manufacturing Practices (GMP) for Stability Studies, Pharmaceutical Quality and Practices

Apply ICH Zonal Classification for Market-Specific Stability Storage

Understanding the Tip: What is zonal classification in stability studies: Zonal classification refers to the segmentation of global markets into distinct climatic zones, as outlined by ICH and WHO. Each zone represents typical temperature and humidity profiles that influence how drug products degrade over time. These zones dictate the long-term and accelerated storage conditions required…

Stability Study Tips